Skip to main content

Advertisement

Table 1 Baseline demographics and data

From: Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis

Parameters Average
Age ± SD (min max) (years) 63.2 ± 11.4 (32–85)
Female, n (%) 195 (91.1)
Female over 60 years old, n (%) 131 (61.1)
BMI ± SD (min max) (kg/m2) 21.3 ± 3.1 (12.3–30.0)
HbA1c (NGSP) (min max) (%) 5.65 ± 0.5 (4.6–9.2)
DAS-ESR ± SD (min max) 3.2 ± 1.1 (0.5–6.6)
HAQ ± SD (min max) 0.8 ± 0.7 (0–2.9)
TSS ± SD (min max) 122.6 ± 108.0 (0–443)
MTX dose ± SD (mg) (min max) 5.6 ± 3.9 (0–14)
Steroid dose ± SD (mg) (min max) 1.77 ± 2.62 (0–15)
bDMARD use, n (%) 67 (31.3)
Bisphosphonate use, n (%) 67(31.3)
Vitamin D use, n (%) 80(37.3)
Observation period (min max) (years) 2.3 (1.2–3.5)
Lumbar spine BMD ± SD (min max) 86.2 ± 18.3 (45.8–151.0)
Total hip-BMD ± SD (min max) 81.8 ± 14.3 (45.0–119.0)
Distal forearm-BMD ± SD (min max) 82.3 ± 22.0 (34.0–140.0)
The annual lumbar spine-BMD change ± SD (min max) − 0.14 ± 2.70
The annual total hip-BMD change ± SD (min max) − 0.46 ± 1.63
The annual distal forearm-BMD change ± SD (min max) − 1.15 ± 1.85
RF ± SD (min max) (U/ml) 86.0 ± 129.4 (0–812.8)
ACPA ± SD (min max) (U/ml) 125.9 ± 113.5 (0–300)
CRP ± SD (min max) (mg/dl) 0.66 ± 1.32 (0–11.7)
TRACP-5b ± SD (min max) (mU/dl) 320.0 ± 149.0 (68–877)
Homocysteine ± SD (min max) (nmol/ml) 9.7 ± 3.5 (3.2–28.0)
Uc-OC ± SD (ng/mL) (min max) 4.8 ± 4.1 (0–23.3)
BAP ± SD (μg/L) (min max) 15.6 ± 6.4 (5.8–43.6)
Urinary pentosidine ± SD(pg/ml)(min max) 47.1 ± 25.9 (11.5–196.0)
  1. BMI body mass index, HbA1c NGSP Hemoglobin A1C National Glycohemoglobin Standardization Program, DAS28-ESR disease activity score in 28 joints-erythrocyte sedimentation rate, HAQ health assessment questionnaire, TSS total Sharp/van der Heijde score, MTX methotrexate, bDMARDs biological disease-modifying anti-rheumatic drugs, BMD bone mineral density (data was shown with young adult mean), RF rheumatoid factor, ACPA anti-cyclic citrullinated peptide antibody, CRP C-reactive protein, TRACP-5b tartrate-resistant acid phosphatase 5b, Uc-OC undercarboxylated osteocalcin, BAP bone-specific alkaline phosphatase